Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dynamics of immune-mediated thyroid dysfunction in patients with advanced renal cell carcinoma receiving checkpoint inhibitor therapy
    Meeting Abstract

    Osorio, J. C.; Patil, S.; Coskey, D. T.; Carlo, M. I.; Feldman, D. R.; Hellmann, M. D.; Voss, M. H.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Trends in aggressive care at the end-of-life for stage IV lung cancer patients
    Meeting Abstract

    Mrad, C.; Abougergi, M. S.; Daly, R. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • In vitro functional analysis of HER2 variants in lung cancers to evaluate their oncogenic activity and predict clinical response to HER2 targeted therapies
    Meeting Abstract

    Offin, M.; Olah, Z. T.; Sabari, J. K.; Tandon, N.; Feldman, D.; Abou-Alfa, G. K.; Lok, B. H.; Burck, N.; Tarcic, G.; Miron, B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Loss-of-function of PBRM1 to predict response to anti-PD-1/PD-L1 therapy in metastatic renal cell carcinoma
    Meeting Abstract

    Miao, D.; Margolis, C.; Martini, D.; Mullane, S. A.; Cullen, D.; Horak, C.; Wind-Rotolo, M.; Hellmann, M. D.; Voss, M. H.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • First-in-class oral ERK1/2 inhibitor Ulixertinib (BVD-523) in patients with advanced solid tumors: Final results of a phase I dose escalation and expansion study
    Meeting Abstract

    Li, B. T.; Janku, F.; Patel, M. R.; Sullivan, R. J.; Flaherty, K.; Buchbinder, E. I.; Lacouture, M. E.; Varghese, A. M.; Wong, D. J. L.; Sznol, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Use of PD-1 pathway inhibitors among patients with non-small cell lung cancer (NSCLC) and preexisting autoimmune disorders
    Meeting Abstract

    Leonardi, G. C.; Gainor, J. F.; Azimi, R. S.; Riess, J.; Rizvi, H.; Hellmann, M. D.; Awad, M. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Afatinib in patients with metastatic HER2-mutant lung cancers: An international multicenter study
    Meeting Abstract

    Lai, W. C. V.; Lebas, L.; Milia, J.; Barnes, T. A.; Gautschi, O.; Peters, S.; Ferrara, R.; Ni, A.; Sabari, J. K.; Clarke, S. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The efficacy of larotrectinib (LOXO-101), a selective tropomyosin receptor kinase (TRK) inhibitor, in adult and pediatric TRK fusion cancers
    Meeting Abstract

    Hyman, D. M.; Laetsch, T. W.; Kummar, S.; DuBois, S. G.; Farago, A. F.; Pappo, A. S.; Demetri, G. D.; El-Deiry, W. S.; Lassen, U. N.; Dowlati, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Estimating long-term survival of PD-L1-expressing, previously treated, non-small cell lung cancer patients who received pembrolizumab in KEYNOTE-001 and -010
    Meeting Abstract

    Hellmann, M. D.; Ma, J.; Garon, E. B.; Hui, R.; Gandhi, L.; Soria, J. C.; Anderson, K. M.; Lubiniecki, G. M.; Piperdi, B.; Herbst, R. S.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • RASA1 and NF1 co-mutated non-small cell lung carcinomas: Cancer genomic data and evaluation of sensitivity to MEK inhibition
    Meeting Abstract

    Hayashi, T.; Desmeules, P.; Smith, R.; Drilon, A. E.; Somwar, R.; Ladanyi, M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save